

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 7.33594687 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 7.33594687 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.33594687 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.33594687 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.33594687 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 7.33594687 |
| 7 | microglial cell activation (GO:0001774) | 6.00547678 |
| 8 | positive regulation of monocyte chemotaxis (GO:0090026) | 5.41758479 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.39907497 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.12119406 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.08854823 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.94973405 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.94973405 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.87299989 |
| 15 | respiratory burst (GO:0045730) | 4.86443789 |
| 16 | cellular response to exogenous dsRNA (GO:0071360) | 4.85245759 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.79829990 |
| 18 | response to host immune response (GO:0052572) | 4.76892097 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.76892097 |
| 20 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.73411203 |
| 21 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.73014704 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.70519666 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 4.69122184 |
| 24 | response to peptidoglycan (GO:0032494) | 4.50865713 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.47578150 |
| 26 | intracellular pH reduction (GO:0051452) | 4.39453584 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 4.38539823 |
| 28 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.35311598 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.28872018 |
| 30 | regulation of monocyte chemotaxis (GO:0090025) | 4.21744255 |
| 31 | response to host (GO:0075136) | 4.15105723 |
| 32 | response to host defenses (GO:0052200) | 4.15105723 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.15105723 |
| 34 | macrophage activation (GO:0042116) | 4.12354940 |
| 35 | pinocytosis (GO:0006907) | 4.10260810 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.09937776 |
| 37 | detection of other organism (GO:0098543) | 4.00112552 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98186675 |
| 39 | cellular extravasation (GO:0045123) | 3.95703076 |
| 40 | detection of bacterium (GO:0016045) | 3.88366262 |
| 41 | glycosphingolipid catabolic process (GO:0046479) | 3.86518508 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84561925 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.81750966 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.77311505 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71641487 |
| 46 | cellular response to interferon-beta (GO:0035458) | 3.67868142 |
| 47 | regulation of chemokine biosynthetic process (GO:0045073) | 3.65142154 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.63044168 |
| 49 | pH reduction (GO:0045851) | 3.60752425 |
| 50 | sphingolipid catabolic process (GO:0030149) | 3.59695062 |
| 51 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.52978369 |
| 52 | superoxide anion generation (GO:0042554) | 3.52861157 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.52738923 |
| 54 | membrane raft organization (GO:0031579) | 3.49955764 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.47844628 |
| 56 | neutrophil activation (GO:0042119) | 3.43598437 |
| 57 | glycolipid catabolic process (GO:0019377) | 3.42840891 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.42719680 |
| 59 | positive thymic T cell selection (GO:0045059) | 3.42378953 |
| 60 | regulation of phospholipase A2 activity (GO:0032429) | 3.41602712 |
| 61 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.41249526 |
| 62 | granulocyte activation (GO:0036230) | 3.40617925 |
| 63 | detection of external biotic stimulus (GO:0098581) | 3.37483606 |
| 64 | negative thymic T cell selection (GO:0045060) | 3.31973822 |
| 65 | positive regulation of macrophage cytokine production (GO:0060907) | 3.30024242 |
| 66 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.27007204 |
| 67 | negative T cell selection (GO:0043383) | 3.26470754 |
| 68 | positive regulation of interleukin-12 production (GO:0032735) | 3.26358931 |
| 69 | membrane lipid catabolic process (GO:0046466) | 3.23871182 |
| 70 | I-kappaB phosphorylation (GO:0007252) | 3.23183288 |
| 71 | regulation of antigen processing and presentation (GO:0002577) | 3.21930974 |
| 72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21237625 |
| 73 | ceramide catabolic process (GO:0046514) | 3.18408251 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.18026724 |
| 75 | leukocyte aggregation (GO:0070486) | 3.17655873 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15038409 |
| 77 | oligosaccharide catabolic process (GO:0009313) | 3.14704355 |
| 78 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.10676858 |
| 79 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09301857 |
| 80 | detection of biotic stimulus (GO:0009595) | 3.08558679 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.08111960 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 3.07189240 |
| 83 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04956568 |
| 84 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.04776275 |
| 85 | regulation of tolerance induction (GO:0002643) | 3.04442574 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03718025 |
| 87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02893220 |
| 88 | positive regulation of mast cell degranulation (GO:0043306) | 3.02893220 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.02839276 |
| 90 | response to muramyl dipeptide (GO:0032495) | 3.01424473 |
| 91 | T cell migration (GO:0072678) | 3.00710847 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00511550 |
| 93 | positive regulation of interferon-beta production (GO:0032728) | 2.99291003 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99093403 |
| 95 | T cell selection (GO:0045058) | 2.99009579 |
| 96 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.93996254 |
| 97 | type I interferon signaling pathway (GO:0060337) | 2.93874842 |
| 98 | cellular response to type I interferon (GO:0071357) | 2.93874842 |
| 99 | positive regulation of mast cell activation (GO:0033005) | 2.93260407 |
| 100 | detection of molecule of bacterial origin (GO:0032490) | 2.93220541 |
| 101 | B cell receptor signaling pathway (GO:0050853) | 2.93203269 |
| 102 | response to type I interferon (GO:0034340) | 2.92445282 |
| 103 | phagocytosis, engulfment (GO:0006911) | 2.92255473 |
| 104 | regulation of leukocyte degranulation (GO:0043300) | 2.91680984 |
| 105 | regulation of mononuclear cell migration (GO:0071675) | 2.90526155 |
| 106 | myeloid leukocyte activation (GO:0002274) | 2.88696781 |
| 107 | tolerance induction (GO:0002507) | 2.88132028 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87183425 |
| 109 | leukocyte mediated cytotoxicity (GO:0001909) | 2.84746237 |
| 110 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.83724488 |
| 111 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.82879621 |
| 112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82440385 |
| 113 | positive T cell selection (GO:0043368) | 2.82177002 |
| 114 | T-helper 1 type immune response (GO:0042088) | 2.79936407 |
| 115 | dendritic cell chemotaxis (GO:0002407) | 2.79074850 |
| 116 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.77751699 |
| 117 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77408001 |
| 118 | T cell costimulation (GO:0031295) | 2.77141290 |
| 119 | regulation of B cell differentiation (GO:0045577) | 2.77113342 |
| 120 | regulation of lymphocyte migration (GO:2000401) | 2.77078479 |
| 121 | cellular response to interleukin-15 (GO:0071350) | 2.76653179 |
| 122 | dendritic cell migration (GO:0036336) | 2.76648760 |
| 123 | B cell mediated immunity (GO:0019724) | 2.75778727 |
| 124 | lymphocyte chemotaxis (GO:0048247) | 2.75244575 |
| 125 | regulation of mast cell degranulation (GO:0043304) | 2.74616735 |
| 126 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73720185 |
| 127 | regulation of mast cell activation (GO:0033003) | 2.73246117 |
| 128 | lymphocyte costimulation (GO:0031294) | 2.73133552 |
| 129 | natural killer cell mediated immunity (GO:0002228) | 2.72283851 |
| 130 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.72283851 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.71707300 |
| 132 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.71684747 |
| 133 | positive regulation of chemokine production (GO:0032722) | 2.71562401 |
| 134 | response to interleukin-15 (GO:0070672) | 2.71543978 |
| 135 | positive regulation of interleukin-6 production (GO:0032755) | 2.71401193 |
| 136 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.71063576 |
| 137 | mast cell activation (GO:0045576) | 2.70812367 |
| 138 | positive regulation of B cell differentiation (GO:0045579) | 2.70356565 |
| 139 | positive regulation of type 2 immune response (GO:0002830) | 2.70151588 |
| 140 | negative regulation of mast cell activation (GO:0033004) | 2.70043431 |
| 141 | response to protozoan (GO:0001562) | 2.69296009 |
| 142 | reactive oxygen species biosynthetic process (GO:1903409) | 2.67202472 |
| 143 | positive regulation of T cell migration (GO:2000406) | 2.66703813 |
| 144 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.65689478 |
| 145 | leukocyte degranulation (GO:0043299) | 2.65394621 |
| 146 | regulation of cellular extravasation (GO:0002691) | 2.65101467 |
| 147 | defense response to protozoan (GO:0042832) | 2.64779562 |
| 148 | positive regulation of leukocyte degranulation (GO:0043302) | 2.64327612 |
| 149 | cellular response to interferon-gamma (GO:0071346) | 2.64251636 |
| 150 | phagocytosis, recognition (GO:0006910) | 2.63411192 |
| 151 | eosinophil chemotaxis (GO:0048245) | 2.63322756 |
| 152 | thymic T cell selection (GO:0045061) | 2.62605347 |
| 153 | positive regulation of interleukin-17 production (GO:0032740) | 2.62578207 |
| 154 | NIK/NF-kappaB signaling (GO:0038061) | 2.62563832 |
| 155 | L-amino acid import (GO:0043092) | 2.62308545 |
| 156 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61819974 |
| 157 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.59400070 |
| 158 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59263184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.74462022 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.58241096 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94660814 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.34976281 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.55557958 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.45378862 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.38306480 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10620850 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98964275 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.98509112 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.70838250 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39380432 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.33917406 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23759988 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16672647 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12735838 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10564456 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06897086 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99355674 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99087818 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95304588 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89733979 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.89125988 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87007927 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80610974 |
| 26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80038723 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78525754 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75784611 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73119157 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71066098 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67900116 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64773663 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57935690 |
| 34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55522901 |
| 35 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54909712 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.52392238 |
| 37 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.50298050 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47787155 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43278841 |
| 40 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42846047 |
| 41 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42846047 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41134669 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41034148 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40996829 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40410344 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35768173 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33523084 |
| 48 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32555666 |
| 49 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31405610 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30407499 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29114779 |
| 52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28805773 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.26614022 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25177281 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25171492 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21105138 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21062145 |
| 58 | * MYB_26560356_Chip-Seq_TH2_Human | 1.17979484 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17496344 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16847300 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.13763514 |
| 62 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11364048 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07214041 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07122942 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06828452 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06563755 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05750678 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05215864 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04822369 |
| 70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04327712 |
| 71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03539390 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01435740 |
| 73 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01290023 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01115592 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00910684 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00900448 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99990259 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99467058 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98740142 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98432961 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98277575 |
| 82 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97318396 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97005165 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96513985 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95396583 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94165718 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94038767 |
| 88 | P300_27268052_Chip-Seq_Bcells_Human | 0.90929592 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90155780 |
| 90 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89930516 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89706271 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89504421 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89323563 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87529671 |
| 95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85882410 |
| 96 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85429063 |
| 97 | MAF_26560356_Chip-Seq_TH1_Human | 0.85238470 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85187805 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84691554 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84186945 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84066210 |
| 102 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.82584341 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82577000 |
| 104 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.82009592 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81898272 |
| 106 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81871504 |
| 107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81731860 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81296236 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80835850 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80298589 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77191267 |
| 112 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76993160 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.76117014 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75098274 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74830857 |
| 116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.74196107 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73987439 |
| 118 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73524399 |
| 119 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73240660 |
| 120 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73081501 |
| 121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72673580 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.72359600 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72356983 |
| 124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.71753151 |
| 125 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.71645220 |
| 126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.71636893 |
| 127 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.71241189 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.71138483 |
| 129 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70410709 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 0.69808898 |
| 131 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.69553975 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69305305 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.67483798 |
| 134 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.66570730 |
| 135 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66406242 |
| 136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.66300374 |
| 137 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.64635260 |
| 138 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.64501210 |
| 139 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.63663556 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63342320 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63078585 |
| 142 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.63076714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.26248056 |
| 2 | MP0006082_CNS_inflammation | 3.84303461 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.65810037 |
| 4 | MP0003436_decreased_susceptibility_to | 3.62861526 |
| 5 | MP0002419_abnormal_innate_immunity | 3.25354927 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.04723204 |
| 7 | MP0009785_altered_susceptibility_to | 2.96392246 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.95721257 |
| 9 | MP0003303_peritoneal_inflammation | 2.94153808 |
| 10 | MP0005387_immune_system_phenotype | 2.89650456 |
| 11 | MP0001790_abnormal_immune_system | 2.89650456 |
| 12 | MP0000685_abnormal_immune_system | 2.74503863 |
| 13 | MP0005025_abnormal_response_to | 2.74295660 |
| 14 | MP0005671_abnormal_response_to | 2.67933811 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.64506054 |
| 16 | MP0003724_increased_susceptibility_to | 2.57841477 |
| 17 | MP0004510_myositis | 2.57455353 |
| 18 | MP0001853_heart_inflammation | 2.50492583 |
| 19 | MP0003075_altered_response_to | 2.45510659 |
| 20 | MP0003690_abnormal_glial_cell | 2.25965325 |
| 21 | MP0001800_abnormal_humoral_immune | 2.17516142 |
| 22 | MP0002723_abnormal_immune_serum | 2.17064938 |
| 23 | MP0001819_abnormal_immune_cell | 2.15949557 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.10959880 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.04934715 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.03955822 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.98007213 |
| 28 | MP0003866_abnormal_defecation | 1.94202043 |
| 29 | MP0002090_abnormal_vision | 1.88191307 |
| 30 | MP0002405_respiratory_system_inflammati | 1.81668550 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.81449334 |
| 32 | MP0000343_altered_response_to | 1.79737348 |
| 33 | MP0001873_stomach_inflammation | 1.76624260 |
| 34 | MP0009764_decreased_sensitivity_to | 1.75159611 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.69713954 |
| 36 | MP0005166_decreased_susceptibility_to | 1.65374270 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.58196305 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.58146788 |
| 39 | MP0005310_abnormal_salivary_gland | 1.57319488 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.54753831 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.50595042 |
| 42 | MP0005360_urolithiasis | 1.50084814 |
| 43 | MP0002006_tumorigenesis | 1.50000481 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.47219934 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.46037738 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.41990270 |
| 47 | MP0009840_abnormal_foam_cell | 1.40643642 |
| 48 | MP0005670_abnormal_white_adipose | 1.31336417 |
| 49 | MP0008469_abnormal_protein_level | 1.30527157 |
| 50 | MP0003828_pulmonary_edema | 1.29323114 |
| 51 | MP0005365_abnormal_bile_salt | 1.24921590 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.24738148 |
| 53 | MP0003136_yellow_coat_color | 1.24136025 |
| 54 | MP0001663_abnormal_digestive_system | 1.22948727 |
| 55 | MP0003448_altered_tumor_morphology | 1.21194246 |
| 56 | MP0004947_skin_inflammation | 1.21071873 |
| 57 | MP0000716_abnormal_immune_system | 1.19657416 |
| 58 | MP0000604_amyloidosis | 1.17905227 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 1.17827119 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.16176070 |
| 61 | MP0008260_abnormal_autophagy | 1.16103101 |
| 62 | MP0002009_preneoplasia | 1.15544399 |
| 63 | MP0000920_abnormal_myelination | 1.15404521 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.15310181 |
| 65 | MP0002254_reproductive_system_inflammat | 1.12472559 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.12074369 |
| 67 | MP0002132_abnormal_respiratory_system | 1.11912288 |
| 68 | MP0001958_emphysema | 1.10963243 |
| 69 | MP0009278_abnormal_bone_marrow | 1.08435995 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.05478297 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02471986 |
| 72 | MP0008438_abnormal_cutaneous_collagen | 1.01082435 |
| 73 | MP0000858_altered_metastatic_potential | 1.00883524 |
| 74 | MP0000490_abnormal_crypts_of | 0.98954697 |
| 75 | MP0000703_abnormal_thymus_morphology | 0.98844962 |
| 76 | MP0001851_eye_inflammation | 0.97337296 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 0.96168168 |
| 78 | MP0001545_abnormal_hematopoietic_system | 0.96168168 |
| 79 | MP0005164_abnormal_response_to | 0.94350935 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.93551844 |
| 81 | MP0005390_skeleton_phenotype | 0.93195443 |
| 82 | MP0003252_abnormal_bile_duct | 0.93126732 |
| 83 | MP0009046_muscle_twitch | 0.90950464 |
| 84 | MP0002398_abnormal_bone_marrow | 0.89591871 |
| 85 | MP0003045_fibrosis | 0.89440852 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.88385531 |
| 87 | MP0005451_abnormal_body_composition | 0.85847914 |
| 88 | MP0002429_abnormal_blood_cell | 0.83257854 |
| 89 | MP0004858_abnormal_nervous_system | 0.83017769 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.82809070 |
| 91 | MP0004883_abnormal_blood_vessel | 0.80387947 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.80365220 |
| 93 | MP0003195_calcinosis | 0.78670070 |
| 94 | MP0001764_abnormal_homeostasis | 0.78155590 |
| 95 | MP0003279_aneurysm | 0.77393826 |
| 96 | MP0003186_abnormal_redox_activity | 0.77306301 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.77092786 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.77087474 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.76187025 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.75591174 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 0.75235393 |
| 102 | MP0005381_digestive/alimentary_phenotyp | 0.75036390 |
| 103 | MP0001984_abnormal_olfaction | 0.74964980 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.74892414 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.74150696 |
| 106 | MP0003646_muscle_fatigue | 0.72602845 |
| 107 | MP0003634_abnormal_glial_cell | 0.72553740 |
| 108 | MP0006054_spinal_hemorrhage | 0.72517666 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.72462480 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.71957661 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.71663020 |
| 112 | MP0000249_abnormal_blood_vessel | 0.71291689 |
| 113 | MP0001666_abnormal_nutrient_absorption | 0.70306961 |
| 114 | MP0005165_increased_susceptibility_to | 0.69697544 |
| 115 | MP0003633_abnormal_nervous_system | 0.68191347 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.67633257 |
| 117 | MP0005174_abnormal_tail_pigmentation | 0.65140073 |
| 118 | MP0003329_amyloid_beta_deposits | 0.65020541 |
| 119 | MP0009763_increased_sensitivity_to | 0.64809844 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.61650765 |
| 121 | MP0002933_joint_inflammation | 0.59061419 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.58260854 |
| 123 | MP0003795_abnormal_bone_structure | 0.57526471 |
| 124 | MP0001881_abnormal_mammary_gland | 0.57156126 |
| 125 | MP0002722_abnormal_immune_system | 0.57020601 |
| 126 | MP0004130_abnormal_muscle_cell | 0.56784858 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.55802379 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.55779415 |
| 129 | MP0008004_abnormal_stomach_pH | 0.54955267 |
| 130 | MP0005388_respiratory_system_phenotype | 0.54878271 |
| 131 | MP0002133_abnormal_respiratory_system | 0.54878271 |
| 132 | MP0003950_abnormal_plasma_membrane | 0.53715726 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.51537945 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.51190597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 8.06209136 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 7.84867985 |
| 3 | Recurrent abscess formation (HP:0002722) | 7.25581477 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.50089949 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.45385659 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.81348339 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.30845375 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.30845375 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 5.30845375 |
| 10 | Loss of speech (HP:0002371) | 5.30303616 |
| 11 | Obstructive lung disease (HP:0006536) | 5.00311458 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 5.00311458 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.72646039 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.45589028 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.34711871 |
| 16 | Gingivitis (HP:0000230) | 3.84352705 |
| 17 | Recurrent skin infections (HP:0001581) | 3.78037480 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.68116524 |
| 19 | Abolished electroretinogram (ERG) (HP:0000550) | 3.57690906 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.46719510 |
| 21 | Encephalitis (HP:0002383) | 3.39714198 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.38907478 |
| 23 | Chronic otitis media (HP:0000389) | 3.32545228 |
| 24 | Progressive visual loss (HP:0000529) | 3.18341015 |
| 25 | Abnormality of complement system (HP:0005339) | 3.14089735 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.13730774 |
| 27 | Vasculitis (HP:0002633) | 3.11433920 |
| 28 | T lymphocytopenia (HP:0005403) | 3.10175682 |
| 29 | Nephritis (HP:0000123) | 3.09911534 |
| 30 | Abnormality of T cell number (HP:0011839) | 3.06935306 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.04841103 |
| 32 | Hemoptysis (HP:0002105) | 3.00165633 |
| 33 | Myositis (HP:0100614) | 2.97109991 |
| 34 | Keratoconjunctivitis (HP:0001096) | 2.95827977 |
| 35 | Cerebral palsy (HP:0100021) | 2.92235926 |
| 36 | Orchitis (HP:0100796) | 2.87523156 |
| 37 | Stomatitis (HP:0010280) | 2.83747353 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.83174700 |
| 39 | Cellulitis (HP:0100658) | 2.83058429 |
| 40 | Meningitis (HP:0001287) | 2.79326814 |
| 41 | Optic neuritis (HP:0100653) | 2.78197084 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.78197084 |
| 43 | Abnormality of T cells (HP:0002843) | 2.75475996 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.74993822 |
| 45 | Poor head control (HP:0002421) | 2.73806861 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73767307 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.72636893 |
| 48 | Thick nail (HP:0001805) | 2.70956519 |
| 49 | Chest pain (HP:0100749) | 2.70248819 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.68165134 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.60145566 |
| 52 | Chronic diarrhea (HP:0002028) | 2.57622205 |
| 53 | Leukocytosis (HP:0001974) | 2.57147661 |
| 54 | Abnormality of the pleura (HP:0002103) | 2.57052534 |
| 55 | Glomerulonephritis (HP:0000099) | 2.56478672 |
| 56 | Anorexia (HP:0002039) | 2.56067713 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.54594275 |
| 58 | Periodontitis (HP:0000704) | 2.53343675 |
| 59 | Epistaxis (HP:0000421) | 2.51345992 |
| 60 | Pustule (HP:0200039) | 2.50063463 |
| 61 | Petechiae (HP:0000967) | 2.49673282 |
| 62 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.48634565 |
| 63 | Axonal loss (HP:0003447) | 2.48572931 |
| 64 | Pulmonary embolism (HP:0002204) | 2.47221160 |
| 65 | Gangrene (HP:0100758) | 2.46061949 |
| 66 | Urticaria (HP:0001025) | 2.45423793 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.44356874 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.42804677 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.42380152 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.41155652 |
| 71 | Gingival bleeding (HP:0000225) | 2.40911006 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.39732121 |
| 73 | Diminished motivation (HP:0000745) | 2.39323082 |
| 74 | Acrocyanosis (HP:0001063) | 2.38994980 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.38364179 |
| 76 | Agammaglobulinemia (HP:0004432) | 2.36721097 |
| 77 | Increased IgE level (HP:0003212) | 2.36463859 |
| 78 | Emphysema (HP:0002097) | 2.36249575 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.35561802 |
| 80 | Malnutrition (HP:0004395) | 2.34541656 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.32632825 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32231005 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32231005 |
| 84 | Apathy (HP:0000741) | 2.31340142 |
| 85 | Granulocytopenia (HP:0001913) | 2.29796625 |
| 86 | Macular degeneration (HP:0000608) | 2.28457907 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24874484 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.24874484 |
| 89 | Episodic fever (HP:0001954) | 2.22691927 |
| 90 | Recurrent viral infections (HP:0004429) | 2.22529123 |
| 91 | Cheilitis (HP:0100825) | 2.22336327 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 2.21521936 |
| 93 | Abnormality of the pericardium (HP:0001697) | 2.21357647 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 2.20933776 |
| 95 | Myocardial infarction (HP:0001658) | 2.19621791 |
| 96 | Eosinophilia (HP:0001880) | 2.18764078 |
| 97 | Joint swelling (HP:0001386) | 2.18566137 |
| 98 | Nasal polyposis (HP:0100582) | 2.18167424 |
| 99 | Polyneuropathy (HP:0001271) | 2.17170728 |
| 100 | Amyloidosis (HP:0011034) | 2.16360538 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15598706 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15598706 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15598706 |
| 104 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14218957 |
| 105 | Prostate neoplasm (HP:0100787) | 2.12990012 |
| 106 | Restrictive lung disease (HP:0002091) | 2.12408718 |
| 107 | Xerostomia (HP:0000217) | 2.12329200 |
| 108 | Disinhibition (HP:0000734) | 2.11952606 |
| 109 | Increased IgM level (HP:0003496) | 2.11288815 |
| 110 | Testicular atrophy (HP:0000029) | 2.11244780 |
| 111 | Hematochezia (HP:0002573) | 2.11207463 |
| 112 | Pancreatitis (HP:0001733) | 2.08644477 |
| 113 | Purpura (HP:0000979) | 2.07932111 |
| 114 | Osteomyelitis (HP:0002754) | 2.07559841 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.06522383 |
| 116 | Neurofibrillary tangles (HP:0002185) | 2.06174424 |
| 117 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.03695241 |
| 118 | J-shaped sella turcica (HP:0002680) | 2.03203518 |
| 119 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02161216 |
| 120 | Abnormality of the nasal mucosa (HP:0000433) | 1.98328980 |
| 121 | IgG deficiency (HP:0004315) | 1.97045699 |
| 122 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96262242 |
| 123 | Osteolytic defects of the hand bones (HP:0009699) | 1.96262242 |
| 124 | Hypochromic anemia (HP:0001931) | 1.96256397 |
| 125 | Vertigo (HP:0002321) | 1.96053334 |
| 126 | Abnormality of B cell number (HP:0010975) | 1.95896333 |
| 127 | Glomerulopathy (HP:0100820) | 1.94609526 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.93334736 |
| 129 | Colitis (HP:0002583) | 1.93133738 |
| 130 | Abnormality of eosinophils (HP:0001879) | 1.92903172 |
| 131 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92893058 |
| 132 | Acne (HP:0001061) | 1.88358474 |
| 133 | Arterial thrombosis (HP:0004420) | 1.82757058 |
| 134 | Chronic sinusitis (HP:0011109) | 1.81075151 |
| 135 | Abnormality of binocular vision (HP:0011514) | 1.79691529 |
| 136 | Diplopia (HP:0000651) | 1.79691529 |
| 137 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77696255 |
| 138 | Skin rash (HP:0000988) | 1.77597942 |
| 139 | Joint hemorrhage (HP:0005261) | 1.77597258 |
| 140 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.77567329 |
| 141 | Tetraparesis (HP:0002273) | 1.75329345 |
| 142 | Hypergammaglobulinemia (HP:0010702) | 1.73022014 |
| 143 | Skin ulcer (HP:0200042) | 1.69128487 |
| 144 | Premature loss of primary teeth (HP:0006323) | 1.65330928 |
| 145 | Increased serum ferritin (HP:0003281) | 1.64899128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.38150958 |
| 2 | BLK | 4.21804995 |
| 3 | MAP3K14 | 3.98208453 |
| 4 | MAP4K1 | 3.83733631 |
| 5 | IRAK4 | 3.24929580 |
| 6 | TBK1 | 3.13299224 |
| 7 | IRAK3 | 2.63993522 |
| 8 | BCKDK | 2.57934211 |
| 9 | TYK2 | 2.39849488 |
| 10 | MST4 | 2.38292964 |
| 11 | PBK | 2.31285236 |
| 12 | GRK6 | 2.14336743 |
| 13 | MAP3K12 | 2.14148401 |
| 14 | IKBKB | 2.11005078 |
| 15 | EPHB1 | 1.98363127 |
| 16 | CSK | 1.92467248 |
| 17 | CSF1R | 1.91396869 |
| 18 | TNK2 | 1.83932751 |
| 19 | KIT | 1.81223294 |
| 20 | TXK | 1.80144595 |
| 21 | JAK1 | 1.76260018 |
| 22 | IKBKE | 1.71708921 |
| 23 | MAP3K3 | 1.65631407 |
| 24 | SYK | 1.55105904 |
| 25 | MAP3K11 | 1.54113913 |
| 26 | GRK1 | 1.51909131 |
| 27 | MAP2K3 | 1.51516353 |
| 28 | JAK3 | 1.43616729 |
| 29 | TAOK1 | 1.35797487 |
| 30 | LYN | 1.35587552 |
| 31 | TESK2 | 1.35496973 |
| 32 | PIM2 | 1.31926619 |
| 33 | TEC | 1.31873055 |
| 34 | ACVR1B | 1.30977567 |
| 35 | GRK7 | 1.28370551 |
| 36 | FGR | 1.28174761 |
| 37 | HCK | 1.28024956 |
| 38 | BMPR2 | 1.22937527 |
| 39 | BTK | 1.22466013 |
| 40 | NUAK1 | 1.16350033 |
| 41 | ERN1 | 1.15214308 |
| 42 | TGFBR2 | 1.12188374 |
| 43 | FES | 1.03949640 |
| 44 | NEK9 | 1.03880069 |
| 45 | BMX | 1.03297127 |
| 46 | CLK1 | 1.02750925 |
| 47 | YES1 | 1.00827223 |
| 48 | ADRBK2 | 0.95672106 |
| 49 | ITK | 0.90771497 |
| 50 | JAK2 | 0.90352132 |
| 51 | MATK | 0.88251385 |
| 52 | TAOK3 | 0.87944156 |
| 53 | ZAP70 | 0.86963475 |
| 54 | MAP3K1 | 0.86201486 |
| 55 | ABL2 | 0.82889920 |
| 56 | LCK | 0.80127342 |
| 57 | TRIB3 | 0.77602789 |
| 58 | TRPM7 | 0.77298927 |
| 59 | TAOK2 | 0.77012977 |
| 60 | FGFR3 | 0.76951219 |
| 61 | STK10 | 0.76861364 |
| 62 | LRRK2 | 0.76155654 |
| 63 | PRKCD | 0.75360107 |
| 64 | MAP2K6 | 0.73219860 |
| 65 | CAMK1D | 0.72119810 |
| 66 | ABL1 | 0.72027451 |
| 67 | MAP3K13 | 0.71831177 |
| 68 | STK24 | 0.71552306 |
| 69 | PRKCQ | 0.71394075 |
| 70 | MAPK15 | 0.71257914 |
| 71 | MST1R | 0.70880253 |
| 72 | CAMKK2 | 0.68804013 |
| 73 | PDK1 | 0.67444637 |
| 74 | IRAK1 | 0.66350464 |
| 75 | DAPK2 | 0.64794888 |
| 76 | TLK1 | 0.64330951 |
| 77 | NLK | 0.62802285 |
| 78 | PRKD2 | 0.61028156 |
| 79 | MYLK | 0.59346105 |
| 80 | PDPK1 | 0.57812015 |
| 81 | CAMKK1 | 0.57371843 |
| 82 | MUSK | 0.56098994 |
| 83 | FRK | 0.56052212 |
| 84 | MARK3 | 0.55766402 |
| 85 | PIM1 | 0.54835883 |
| 86 | KDR | 0.53991494 |
| 87 | RPS6KC1 | 0.53456593 |
| 88 | RPS6KL1 | 0.53456593 |
| 89 | MAP2K2 | 0.51176594 |
| 90 | PKN1 | 0.48013476 |
| 91 | DMPK | 0.47606635 |
| 92 | MAPK7 | 0.47234765 |
| 93 | MAPKAPK3 | 0.47086819 |
| 94 | FYN | 0.46701283 |
| 95 | CDC42BPA | 0.46326071 |
| 96 | PIK3CG | 0.46296505 |
| 97 | DAPK3 | 0.45597584 |
| 98 | EIF2AK2 | 0.43513601 |
| 99 | ERBB3 | 0.43461218 |
| 100 | IGF1R | 0.42966856 |
| 101 | BMPR1B | 0.42293574 |
| 102 | EPHA3 | 0.41962802 |
| 103 | HIPK2 | 0.41010448 |
| 104 | PIK3CA | 0.40835448 |
| 105 | CHUK | 0.39260524 |
| 106 | MAP3K2 | 0.38887917 |
| 107 | WNK4 | 0.38876278 |
| 108 | CDK19 | 0.38874937 |
| 109 | PRKCE | 0.38826526 |
| 110 | MAP3K5 | 0.37435969 |
| 111 | IRAK2 | 0.37218652 |
| 112 | MAPK12 | 0.36950585 |
| 113 | PAK4 | 0.34862412 |
| 114 | PTK6 | 0.34450275 |
| 115 | RIPK1 | 0.33779257 |
| 116 | NTRK2 | 0.33431324 |
| 117 | CASK | 0.32395397 |
| 118 | EIF2AK3 | 0.31895956 |
| 119 | RPS6KA6 | 0.31688710 |
| 120 | EGFR | 0.31338340 |
| 121 | PRPF4B | 0.31218109 |
| 122 | MAPKAPK2 | 0.31082055 |
| 123 | MOS | 0.30880432 |
| 124 | SIK3 | 0.30640860 |
| 125 | MAPK11 | 0.29492336 |
| 126 | RPS6KA4 | 0.28731697 |
| 127 | GRK5 | 0.28066412 |
| 128 | PRKG2 | 0.27729464 |
| 129 | INSR | 0.27468479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.03851724 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.98261787 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.84020811 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.68462758 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.40107918 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.32322190 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.27899713 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.27248192 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.26489577 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.25562020 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25552317 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 2.13946928 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.02500675 |
| 14 | Salmonella infection_Homo sapiens_hsa05132 | 1.97331809 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84298918 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75912697 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73620826 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72449677 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68831722 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.66821579 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65987183 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63498307 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.54518949 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.53938124 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.53819349 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48481295 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45294368 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44688712 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.41880600 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38808181 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37266459 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.36004743 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33783916 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27187161 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25956793 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25569299 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20517315 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15853251 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.14241082 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12204665 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11790346 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07451027 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 1.07180580 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.00650027 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99226476 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98991506 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97208151 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95157939 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93260401 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91380323 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91195158 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.91018393 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91004708 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.87676896 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87324346 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86844146 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86350562 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84810942 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83111596 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82380756 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82072577 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81880298 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81135186 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80706034 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.78057840 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74041417 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73821035 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.70104929 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69817081 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68173773 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67831887 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67593952 |
| 73 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64124197 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61873347 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61402549 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59733104 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56512312 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56350281 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55734267 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.55546626 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52371063 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.51862503 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51692597 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49907409 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48126989 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48071852 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47883883 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46103794 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45875262 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44366111 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44308563 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42875943 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42834891 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42735862 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40086550 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40055670 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38161080 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37827358 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37261633 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.36286929 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35473526 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34141548 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32575851 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.31005467 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29771890 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29727132 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28975040 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28792834 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28691390 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28405531 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28030490 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27964028 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.27853490 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27809773 |
| 115 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27749397 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26718206 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26268982 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.25786536 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24546057 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.23818520 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23216527 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23071098 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22120828 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21520916 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21133713 |
| 126 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.20399879 |

